Latest news
In a first, WuXi AppTec tops Lonza’s six-month revenue despite Pentagon scrutiny - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 17:59:00 GMTAddressing China’s Rise in Biotech by Removing Barriers: Q&A with John Stanford - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 10:07:22 GMT"From the Biosecure Act to Investment Restrictions" U.S. Unleashes Sweeping Curbs on Chinese Biotech, Prioritizing Security Risk Mitigation and Strategic Dominance - economy.aceconomy.ac · Wed, 29 Jul 2026 08:45:21 GMTAs pharma descends on China for deals, BIOSECURE Act raises intellectual property risk - biospace.combiospace.com · Tue, 28 Jul 2026 04:38:17 GMT